Level Chart

Basic Info

Regeneron Pharmaceuticals (REGN) - Other Revenue is at a current level of 212.50M, up from 138.30M last quarter and up from 127.70M one year ago. This is a change of 53.65% from last quarter and 66.41% from one year ago.

Region United States
Source FinChat.io

Data provided via FinChat.io

Stats

Last Value 212.50M
Latest Period Dec 2023
Last Updated Feb 2 2024, 17:26 EST
Average Growth Rate 89.63%
Value from Last Quarter 138.30M
Change from Last Quarter 53.65%
Value from 1 Year Ago 127.70M
Change from 1 Year Ago 66.41%
Frequency Quarterly
Unit USD
Adjustment N/A

Historical Data

View and export this data back to 2019. Upgrade now.
Date Value
December 31, 2023 212.50M
September 30, 2023 138.30M
June 30, 2023 69.30M
March 31, 2023 116.00M
December 31, 2022 127.70M
September 30, 2022 84.20M
June 30, 2022 59.20M
March 31, 2022 94.00M
December 31, 2021 86.20M
Date Value
September 30, 2021 99.00M
June 30, 2021 46.00M
March 31, 2021 50.00M
December 31, 2020 123.40M
September 30, 2020 158.60M
June 30, 2020 211.80M
March 31, 2020 63.20M
December 31, 2019 95.50M

Basic Info

Regeneron Pharmaceuticals (REGN) - Other Revenue is at a current level of 212.50M, up from 138.30M last quarter and up from 127.70M one year ago. This is a change of 53.65% from last quarter and 66.41% from one year ago.

Region United States
Source FinChat.io

Data provided via FinChat.io

Stats

Last Value 212.50M
Latest Period Dec 2023
Last Updated Feb 2 2024, 17:26 EST
Average Growth Rate 89.63%
Value from Last Quarter 138.30M
Change from Last Quarter 53.65%
Value from 1 Year Ago 127.70M
Change from 1 Year Ago 66.41%
Frequency Quarterly
Unit USD
Adjustment N/A

Related Securities

Symbol Name Change %
REGN Regeneron Pharmaceuticals Inc -3.43%